Effectiveness cognitive behavior therapy based on Coping Cat in reducing symptoms in children with anxiety disorders ranged from 8 to 10 year-old

Effectiveness cognitive behavior therapy based on Coping Cat in reducing anxiety, depression and behavioral symptoms in children with anxiety disorders ranged from 8 to 10 year-old

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT2013090414565N1

Enrollment

Registered

2014-05-24

Start date

2012-05-21

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Condition 1: Generalized anxiety disorder of childhood. Condition 2: Social anxiety disorder of childhood. Condition 3: Separation anxiety disorder of childhood. Overanxious disorder Social anxiety disorder of childhood Separation anxiety disorder of childhood

Interventions

Intervention 1: Intervention was 16 sessions (each session is 45 minutes in a week) of cognitive behavior therapy based on Coping Cat schedule. The Coping Cat program is a cognitive-behavioral interve

(2) clarifying feelings in anxiety-provoking situations

(3) developing a coping plan

and (4) evaluating performance and administering self-reinforcement. Intervention 2: The control group received no intervention and was placed on a waiting list for treatment.

Behavior

Intervention was 16 sessions (each session is 45 minutes in a week) of cognitive behavior therapy based on Coping Cat schedule. The Coping Cat program is a cognitive-behavioral intervention that helps

and (4) evaluating performance and administering self-reinforcement.

The control group received no intervention and was placed on a waiting list for treatment.

Eligibility

Sex/Gender

All

Age

8 Years to 10 Years

Inclusion criteria

Inclusion criteria: Inclusion criterion: Having diagnostic criteria for anxiety disorders; eight to 10 year-old children; patient' parent consent for participate in research; the availability of the patient during treatment and follow-up period; stable on the same dose if use psychotropic medications. Exclusion criteria: Having any kind of psychosis disorder; having pervasive developmental disorder; giving another psychological treatment such as cognitive behavior therapy and behavior therapy prior to or simultaneous with treatment.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Attention deficit/hyperactivity symptoms. Timepoint: Before treatment, at the end of treatment, and after a 1/5 and 3-month follow-up. Method of measurement: Child Behavior Checklist.;Anxiety symptoms. Timepoint: Before treatment, at the end of treatment, and after a 1/5 and 3-month follow-up. Method of measurement: Child Behavior Checklist.;Depression symptoms. Timepoint: Before treatment, at the end of treatment, and after a 1/5 and 3-month follow-up. Method of measurement: Child Behavior Checklist.;Oppositional defaint symptoms. Timepoint: Before treatment, at the end of treatment, and after a 1/5 and 3-month follow-up. Method of measurement: Child Behavior Checklist.;Somatic symptoms. Timepoint: Before treatment, at the end of treatment, and after a 1/5 and 3-month follow-up. Method of measurement: Child Behavior Checklist.;Conduct symptoms. Timepoint: Before treatment, at the end of treatment, and after a 1/5 and 3-month follow-up. Method of measurement: Child Behavior Checklist.	—

Measure

Time frame

Attention deficit/hyperactivity symptoms. Timepoint: Before treatment, at the end of treatment, and after a 1/5 and 3-month follow-up. Method of measurement: Child Behavior Checklist.;Anxiety symptoms. Timepoint: Before treatment, at the end of treatment, and after a 1/5 and 3-month follow-up. Method of measurement: Child Behavior Checklist.;Depression symptoms. Timepoint: Before treatment, at the end of treatment, and after a 1/5 and 3-month follow-up. Method of measurement: Child Behavior Checklist.;Oppositional defaint symptoms. Timepoint: Before treatment, at the end of treatment, and after a 1/5 and 3-month follow-up. Method of measurement: Child Behavior Checklist.;Somatic symptoms. Timepoint: Before treatment, at the end of treatment, and after a 1/5 and 3-month follow-up. Method of measurement: Child Behavior Checklist.;Conduct symptoms. Timepoint: Before treatment, at the end of treatment, and after a 1/5 and 3-month follow-up. Method of measurement: Child Behavior Checklist.

—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactFirouzeh Zarghami

Shahed University

firouzeh_zarghami@yahoo.com+98 21 6602 1735

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026